Novocardia™ Named Among New York City’s Top 101 Health Care Companies and Startups of 2021
NEWS & INSIGHTS
NEW YORK, Nov. 4, 2021— Novocardia, a value-based cardiovascular disease care delivery platform, today announced that it has been named one of the ‘101 Top New York City Health Care Companies and Startups of 2021′ by BestStartup.us.
The BestStartup.us list features NYC-based health care companies and startups chosen by industry professionals for exceptional performance in innovation, growth, management, and societal impact. From cutting-edge startups to established brands, Novocardia joins the ranks of companies like Peloton, Cedar, Spring Health, LetsGetChecked, Oscar Health, Spring Health and Zocdoc, bringing innovative ideas and products to market, delivering exceptional growth, and addressing important societal challenges.
“Novocardia is honored to be named one of the top health care companies in New York City by BestStartup.us, as we work to transform how cardiovascular disease care is delivered in the United States,” said Daniel Blumenthal, MD, MBA, Chief Executive Officer of Novocardia.
“Cardiovascular disease is the single largest driver of health care spending in the United States, and accounts for approximately $320 billion in direct medical spending each year. We are focused on helping cardiologists to provide better care at lower cost and improving access to high quality cardiovascular disease care.”*
Founded in 2020 by two cardiologists – Dr. Dan Blumenthal and Dr. Julius Torelli, FACC – Novocardia is committed to building a network of leading cardiologists and investing in their practices so that they can grow and adapt to changes in the health care landscape, including the shift to fee-for-value reimbursement models. Novocardia is focused on improving patient quality and outcomes through proactive and prevention-focused care, a proprietary actuarial and quality-focused analytics platform, and aligned partnerships with health plans and referral partners.
“As Novocardia continues to expand in 2022, the key to our success remains the same – putting cardiologists, and their patients, at the center of care,” said Dr. Torelli, Novocardia’s Chief Medical Officer. “We invest in and partner with cardiologists in an increasingly complex care delivery and payment environment. With our support, cardiologists can succeed at delivering high-quality, high-value care that benefits patients, as well as health plans, primary care groups, and other referral sources.”
Founded in 2020, Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States and help patients with heart and vascular disease live longer, healthier, and more satisfying lives. Novocardia is committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care. To learn more about Novocardia, please visit www.novocardiahealth.com.
Annually, BestStartup.us awards the most successful startups in the U.S. with its lists featuring companies who are pushing the limits of innovation to solve critical problems and challenges. Created by Fupping LTD, a London-based media company, the mission of BestStartUp.us is to promote the greatest American companies, businesses and innovations on the global stage boosting inbound investment by addressing the information asymmetry between small innovative startups and institutional investors.
* Sources: United States Centers for Disease Control. Available at: https://www.cdc.gov/chronicdisease/about/costs/index.htm and www.cdcfoundation.org/pr/2015/heart-disease-and-stroke-cost-america-nearly-1-billion-day-medical-costs-lost-productivity
Novocardia™ Recognized as a Rising
Disruptor by Bernstein in U.S. Health
Novocardia™ Enters Into
Partnership with MedAxiom™
Key Additions to Leadership Team
Accelerating Company’s Mission
Partnership with First Coast Heart
& Vascular Center
of Cardiovascular Disease Care in Northeast Florida
$53.7 Million Financing Led
by Deerfield Management
and Value of Cardiovascular Care in the United States